Parkinson disease articles published in 2018 reveal deeper dives into factors that include the impact of sleep and fatigue on symptoms.
FDA Grants Regenerative Medicine Advanced Therapy Designation to Kyverna's KYV-101 for Refractory Stiff-Person Syndrome
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
Advances in Therapeutic Management for Parkinson Disease and Essential Tremor
Paradigm Shift in Parkinson’s Disease Diagnosis
NeuroVoices: David Shprecher, DO, MSci, FAAN, on Current and Future Directions in Biomarker Testing for Atypical Parkinsonism
New FNIH Initiative Looks to Expedite Parkinson Disease Diagnosis Through Validated Biomarkers